Six disease combo vaccine, VAXELIS, receives FDA nod

Global health care company, Sanofi, announced Wednesday that the US Food and Drug Administration (FDA) approved the pediatric hexavalent combination vaccine, VAXELISa . VAXELIS was developed as part of a joint partnership between Sanofi and MSD (Merck) for use as a three dose series in children from 6 weeks through 4 years of age (prior to the ["]

The post Six disease combo vaccine, VAXELIS, receives FDA nod appeared first on Outbreak News Today.